Eurobio Scientific SA Cash Flow-to-Debt Ratio
Eurobio Scientific SA cash flow-to-debt ratio. Eurobio Scientific SA (ALERS) has a Cash Flow-to-Debt Ratio of 0.07x as of June 2025, meaning its operating cash flow of €5.36 Million could theoretically repay 0% of its total liabilities (€78.26 Million) in one year. Check ALERS cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Eurobio Scientific SA (2007–2024)
Cash flow-to-debt ratio of Eurobio Scientific SA from 2007 to 2024. Historical debt coverage capacity for Eurobio Scientific SA across 18 annual periods. Check Eurobio Scientific SA total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Eurobio Scientific SA Cash Flow-to-Debt Ratio by Year (2007–2024)
Eurobio Scientific SA cash flow-to-debt ratio by year from 2007 to 2024. Year-by-year debt coverage analysis for Eurobio Scientific SA. For the full cash flow conversion analysis, see cash efficiency ratio of Eurobio Scientific SA.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.21x | €16.70 Million | €78.31 Million | ▲ +12.5% |
| 2023 | 0.19x | €26.77 Million | €141.16 Million | ▼ -30.6% |
| 2022 | 0.27x | €43.07 Million | €157.75 Million | ▼ -79.7% |
| 2021 | 1.35x | €65.92 Million | €49.00 Million | ▲ +57.8% |
| 2020 | 0.85x | €54.93 Million | €64.45 Million | ▲ +659.0% |
| 2019 | 0.11x | €4.99 Million | €44.44 Million | ▲ +964.7% |
| 2018 | -0.01x | €-523.00K | €40.27 Million | ▼ -120.9% |
| 2017 | 0.06x | €2.48 Million | €39.88 Million | ▲ +136.8% |
| 2016 | -0.17x | €-3.32 Million | €19.66 Million | ▲ +14.4% |
| 2015 | -0.20x | €-2.44 Million | €12.40 Million | ▲ +26.9% |
| 2014 | -0.27x | €-3.38 Million | €12.55 Million | ▲ +29.3% |
| 2013 | -0.38x | €-4.90 Million | €12.85 Million | ▼ -20.0% |
| 2012 | -0.32x | €-4.45 Million | €13.99 Million | ▲ +78.7% |
| 2011 | -1.49x | €-6.02 Million | €4.04 Million | ▼ -210.4% |
| 2010 | -0.48x | €-5.80 Million | €12.07 Million | ▲ +20.5% |
| 2009 | -0.60x | €-6.71 Million | €11.09 Million | ▼ -26.4% |
| 2008 | -0.48x | €-9.62 Million | €20.11 Million | ▼ -89.3% |
| 2007 | -0.25x | €-4.93 Million | €19.52 Million | — |